avrg: GSE58827: Dynamics of the Mouse Liver
Name | miRBASE accession |
---|---|
mmu-miR-196a-5p
|
MIMAT0000518 |
mmu-miR-196b-5p
|
MIMAT0001081 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 8.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.1 | 9.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 2.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.4 | 1.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.4 | 1.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.4 | 1.8 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 2.0 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.3 | 1.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.3 | 0.8 | GO:1990168 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 2.5 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 1.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.3 | 1.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 1.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 3.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.6 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
0.2 | 0.6 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.2 | 1.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.5 | GO:0060574 | bronchiole development(GO:0060435) intestinal epithelial cell maturation(GO:0060574) |
0.2 | 2.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 0.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.1 | 0.5 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.1 | 0.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.6 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) facioacoustic ganglion development(GO:1903375) |
0.1 | 0.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 0.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 1.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.5 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.1 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 1.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) regulation of enamel mineralization(GO:0070173) |
0.1 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 5.1 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.1 | 0.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 2.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 1.0 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 2.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.4 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 4.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 1.9 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.0 | 0.6 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 2.4 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.0 | 0.1 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.0 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 5.2 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.0 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 1.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.3 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 8.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.8 | 2.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.2 | 2.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 0.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 2.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.5 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.1 | 2.3 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 4.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.6 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.0 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 2.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 2.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 1.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 2.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 5.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.9 | 2.7 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.5 | 4.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.4 | 12.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 2.0 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.3 | 1.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.3 | 4.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 2.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 2.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 2.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.5 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.1 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 1.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 3.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 2.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 2.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 3.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.5 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.3 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 1.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 1.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 2.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 2.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 1.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.1 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.0 | 0.5 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 2.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 12.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 8.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 2.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 2.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 5.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 2.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 3.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 12.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 1.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 2.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 3.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 1.4 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 3.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |